Publikationen, an denen er mitarbeitet Maurizio Bendandi (3)

2016

  1. Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy

    Oncotarget, Vol. 7, Núm. 4, pp. 4522-4530

2007

  1. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer

    Expert Opinion on Biological Therapy, Vol. 7, Núm. 5, pp. 599-615

2006

  1. Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena

    Clinical Cancer Research